Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.
about
Do HMG-CoA reductase inhibitors affect fibrinogen?Cholesterol lowering and coronary artery disease: mechanisms of risk reduction.Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.Beneficial effects of statins in coronary artery disease--beyond lowering cholesterol.Pharmacological effects of HMG CoA reductase inhibitors other than lipoprotein modulation.Statins in the 21st century: end of the simple story?Lack of therapeutic interchangeability of HMG-CoA reductase inhibitors.Niacin extended-release/lovastatin: combination therapy for lipid disorders.Arterial hypertension and ischaemic stroke.Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry.The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study.Pravastatin improves postprandial endothelial dysfunction and hemorheological deterioration in patients with effort angina pectoris.Lipid modifying agents: mechanisms of action and reduction of cardiovascular disease.The effects of converting from simvastatin to atorvastatin on plasminogen activator inhibitor type-1.Long-term effect of lipid-lowering therapy on atherosclerosis of abdominal aorta in patients with hypercholesterolemia: noninvasive evaluation by a new image analysis program.Hemostatic effects of atorvastatin versus simvastatin.Platelet and haemorheological markers in 'high risk' hypertensives are improved by tighter blood pressure control and cardiovascular risk management: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation.Statin drugs do not affect serum complement activation in vitro.
P2860
Q32052986-B4EF1467-3762-49F1-82FC-23E0DDD306B0Q33538129-BA87E402-D096-465F-8AF9-A4138AFF09C0Q33935872-BD55F79D-7FC8-4BFC-A3CC-73737FC2196FQ34122524-048E7C8D-D9B7-44A1-B2B0-30AF67BDEE6CQ34373712-7C5C7D14-86FF-453E-9C2E-362AB304DF78Q34481748-0899D17A-45C8-43D5-B8C5-450A2B7B4717Q35009456-89AF1929-EB96-4370-881B-EADF3332C474Q35020544-3BB53D1A-342B-42BC-9C4D-BC579400529CQ35098824-34DC92B8-EC4F-4330-9748-70735926D0C4Q35639538-858310FB-EE50-432D-8994-0752719D4598Q36106351-AF478246-5F06-4E28-9821-1A9C27E2B8E4Q38843355-A224F128-4F39-428E-9DA4-D8B027E40810Q41464550-F59F3819-9CCF-43DE-8063-4B2658C74592Q43673473-AB1115E7-3092-45E5-83E7-77C6F2AE5380Q43894500-9C5A9339-37B9-4C78-9163-D6CFBDE4FBFFQ44378136-3F33AA56-632F-44C9-AD05-DCA7E6C6C788Q44700528-078BAEAE-117F-4C3D-B18C-179DEAEF0F33Q44877647-C357B785-9E21-410A-8ED1-00AEB1333498Q44967045-CC7CAF0B-0356-47D6-9C24-C96D85AEB117
P2860
Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Effects of pravastatin sodium ...... type II hyperlipoproteinemia.
@en
Effects of pravastatin sodium ...... type II hyperlipoproteinemia.
@nl
type
label
Effects of pravastatin sodium ...... type II hyperlipoproteinemia.
@en
Effects of pravastatin sodium ...... type II hyperlipoproteinemia.
@nl
prefLabel
Effects of pravastatin sodium ...... type II hyperlipoproteinemia.
@en
Effects of pravastatin sodium ...... type II hyperlipoproteinemia.
@nl
P2093
P1433
P1476
Effects of pravastatin sodium ...... type II hyperlipoproteinemia.
@en
P2093
P304
P356
10.1016/0021-9150(95)05757-9
P577
1996-05-01T00:00:00Z